These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23081821)

  • 1. CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy.
    Ke CC; Liu RS; Yang AH; Liu CS; Chi CW; Tseng LM; Tsai YF; Ho JH; Lee CH; Lee OK
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):61-71. PubMed ID: 23081821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.
    Piao LS; Hur W; Kim TK; Hong SW; Kim SW; Choi JE; Sung PS; Song MJ; Lee BC; Hwang D; Yoon SK
    Cancer Lett; 2012 Feb; 315(2):129-37. PubMed ID: 22079466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
    Wang M; Li X; Qu Y; Xu O; Sun Q
    Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
    Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
    Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
    PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.
    Chen Y; Zhang F; Tsai Y; Yang X; Yang L; Duan S; Wang X; Keng P; Lee SO
    Radiat Oncol; 2015 Nov; 10():227. PubMed ID: 26572130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.
    Jamal M; Rath BH; Tsang PS; Camphausen K; Tofilon PJ
    Neoplasia; 2012 Feb; 14(2):150-8. PubMed ID: 22431923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of 14-3-3ζ enhances radiosensitivity and radio-induced apoptosis in CD133(+) liver cancer stem cells.
    Lee YK; Hur W; Lee SW; Hong SW; Kim SW; Choi JE; Yoon SK
    Exp Mol Med; 2014 Feb; 46(2):e77. PubMed ID: 24556826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin.
    Friedman S; Lu M; Schultz A; Thomas D; Lin RY
    PLoS One; 2009; 4(4):e5395. PubMed ID: 19404394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 induces tumour-initiating properties in HEK293 cells.
    Canis M; Lechner A; Mack B; Zengel P; Laubender RP; Koehler U; Heissmeyer V; Gires O
    Tumour Biol; 2013 Feb; 34(1):437-43. PubMed ID: 23150174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset.
    Kucerova L; Feketeova L; Kozovska Z; Poturnajova M; Matuskova M; Nencka R; Babal P
    Thyroid; 2014 Mar; 24(3):520-32. PubMed ID: 24073856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of HIF-2α and its anti-radiotherapy effect in lung cancer stem cells.
    Sun JC; He F; Yi W; Wan MH; Li R; Wei X; Wu R; Niu DL
    Genet Mol Res; 2015 Dec; 14(4):18110-20. PubMed ID: 26782458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma.
    Zhuang HW; Mo TT; Hou WJ; Xiong GX; Zhu XL; Fu QL; Wen WP
    Oncol Rep; 2013 Jul; 30(1):57-63. PubMed ID: 23604326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
    Mei D; Lv B; Chen B; Xiao S; Jiang J; Xie Y; Jiang L
    PLoS One; 2017; 12(8):e0182835. PubMed ID: 28817605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.